CC
OM icon

Cannell & Co’s Outset Medical OM Stock Holding History

Cannell & Co’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,064
Closed -$725K – 281
2022
Q1 		$725K Hold
1,064
– – 0.02% 203
2021
Q4 		$736K Hold
1,064
– – 0.02% 202
2021
Q3 		$789K Sell
1,064
-171
-14% -$117K 0.02% 193
2021
Q2 		$926K Buy
+1,235
New +$944K 0.03% 187

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Cannell & Co's OM Position: Q2 2022 in Review

Cannell & Co sold out of Outset Medical (OM) in Q2 2022, closing a stake of 1,064 shares — an estimated $725K sold.

Cannell & Co first reported a position in OM in Q2 2021 and held it in 4 quarters. The position peaked at $926K in Q2 2021. 149 funds tracked by Wall St. Rank hold OM as of Q2 2022.

  • Cannell & Co reported no remaining Outset Medical position as of Q2 2022 after selling out during the quarter.
  • Cannell & Co sold 1,064 Outset Medical shares in Q2 2022, an estimated $725K.
  • Cannell & Co first reported a position in Outset Medical in Q2 2021 and held it in 4 quarters.
  • Cannell & Co's Outset Medical position peaked at $926K in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Outset Medical as of Q2 2022.

Based on Cannell & Co's 13F filing for Q2 2022, filed 8 Aug 2022.